Clinical Cancer Research, Vol 2, Issue 8 1427-1433, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression

B Seliger, A Hohne, A Knuth, H Bernhard, B Ehring, R Tampe and C Huber
The Johannes Gutenberg University, Third Department of Internal Medicine, Division of Hematology/Oncology, Langenbeckstr. 1, 55131 Mainz, Germany.

Suppression of MHC class I expression is thought to allow tumor cells to escape immune surveillance mediated by CD8(+) CTLs. For stable MHC class I surface expression, multiple protein interactions are required for efficient assembly of MHC class I heavy chain and beta 2-microglobulin with endogenous peptides. Peptide processing and transport into the endoplasmic reticulum involves the genes of the transporters associated with antigen processing, TAP-1 and TAP-2, and the two components of the proteasome complex, the low molecular weight proteins LMP-2 and LMP-7. We selected human renal cell carcinoma (RCC) cells derived from a tumor that is thought to be controlled by host immunity to study the MHC class I antigen presentation machinery. Eleven RCC lines established from primary tumors were investigated for the mRNA and protein expression of MHC class I, TAP, and LMP genes. In addition, membrane stability of MHC class I was determined by incubation of the RCC cell lines at low temperature and in the presence of exogenous HLA-binding peptides. Our results revealed the existence of two different phenotypes of RCC cell lines. Group I displayed temperature-stable MHC class I surface expression associated with high, and in most cases coordinated, expression of MHC class I heavy and light chain, TAP and LMP transcripts, and proteins. Group II demonstrated a marked MHC class I instability at 37 degreesC associated with low but coordinated expression of the respective transcripts and proteins. MHC class I membrane expression of group II, but not of group I RCC cells, could be stabilized by incubation with specific MHC class I binding peptides. These results suggest an important role of the genes of the antigen presentation machinery in stable and efficient MHC class I surface expression of RCC cells. However, it has still to be defined whether deficient antigen processing is one of the mechanisms of RCC cells to escape the surveillance of the immune system.

This article has been cited by other articles:

				H. Norell, M. Carlsten, T. Ohlum, K.-J. Malmberg, G. Masucci, K. Schedvins, W. Altermann, D. Handke, D. Atkins, B. Seliger, et al. Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity. Cancer Res., June 15, 2006; 66(12): 6387 - 6394. [Abstract] [Full Text] [PDF]

				K. Kronfeld, E. Hochleitner, S. Mendler, J. Goldschmidt, R. Lichtenfels, F. Lottspeich, H. Abken, and B. Seliger B7/CD28 Costimulation of T Cells Induces a Distinct Proteome Pattern Mol. Cell. Proteomics, December 1, 2005; 4(12): 1876 - 1887. [Abstract] [Full Text] [PDF]

				B. Cao, X. Tian, Y. Li, P. Jiang, T. Ning, H. Xing, Y. Zhao, C. Zhang, X. Shi, D. Chen, et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China Carcinogenesis, July 1, 2005; 26(7): 1280 - 1284. [Abstract] [Full Text] [PDF]

				L. Marques, M. Brucet, J. Lloberas, and A. Celada STAT1 Regulates Lipopolysaccharide- and TNF-{alpha}-Dependent Expression of Transporter Associated with Antigen Processing 1 and Low Molecular Mass Polypeptide 2 Genes in Macrophages by Distinct Mechanisms J. Immunol., July 15, 2004; 173(2): 1103 - 1110. [Abstract] [Full Text] [PDF]

				B. Seliger, D. Atkins, M. Bock, U. Ritz, S. Ferrone, C. Huber, and S. Storkel Characterization of Human Lymphocyte Antigen Class I Antigen-processing Machinery Defects in Renal Cell Carcinoma Lesions with Special Emphasis on Transporter-associated with Antigen-processing Down-Regulation Clin. Cancer Res., May 1, 2003; 9(5): 1721 - 1727. [Abstract] [Full Text] [PDF]

				C. I. Fine, C. D. Han, X. Sun, Y. Liu, and J. A. McCutcheon Tobacco Reduces Membrane HLA Class I That Is Restored by Transfection with Transporter Associated with Antigen Processing 1 cDNA J. Immunol., November 15, 2002; 169(10): 6012 - 6019. [Abstract] [Full Text] [PDF]

				E. Arons, V. Kunin, C. Schechter, and R. Ehrlich Organization and Functional Analysis of the Mouse Transporter Associated with Antigen Processing 2 Promoter J. Immunol., March 15, 2001; 166(6): 3942 - 3951. [Abstract] [Full Text] [PDF]

				S. E. Dovhey, N. S. Ghosh, and K. L. Wright Loss of Interferon-{{gamma}} Inducibility of TAP1 and LMP2 in a Renal Cell Carcinoma Cell Line Cancer Res., October 1, 2000; 60(20): 5789 - 5796. [Abstract] [Full Text]

				P. Chames, S. E. Hufton, P. G. Coulie, B. Uchanska-Ziegler, and H. R. Hoogenboom Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library PNAS, July 5, 2000; 97(14): 7969 - 7974. [Abstract] [Full Text] [PDF]

				A. K. Johnsen, D. J. Templeton, M.-S. Sy, and C. V. Harding Deficiency of Transporter for Antigen Presentation (TAP) in Tumor Cells Allows Evasion of Immune Surveillance and Increases Tumorigenesis J. Immunol., October 15, 1999; 163(8): 4224 - 4231. [Abstract] [Full Text] [PDF]